Document Preview Unavailable
The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen
Geng, Nan; Su, Jingwei; Liu, Zhikun; Ding, Cuimin; Xie, Shaonan; et al. Technology in Cancer Research & Treatment Vol. 20, (Jan 2021).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library